Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 5 (2008), Issue 8 (August)

1. Efficacy and safety of a hip flexion assist orthosis in ambulatory multiple sclerosis patients.
   Arch Phys Med Rehabil, 89(8): 1611-7. [Abstract] [Full-text]
2. Ratings of perceived exertion during aerobic exercise in multiple sclerosis.
   Arch Phys Med Rehabil, 89(8): 1570-4. [Abstract] [Full-text]
3. Self-generation to improve learning and memory of functional activities in persons with multiple sclerosis: meal preparation and managing finances.
   Arch Phys Med Rehabil, 89(8): 1514-21. [Abstract] [Full-text]
4. Cortical recruitment during selective attention in multiple sclerosis: an fMRI investigation of individual differences.
   Neuropsychologia, 46(12): 2888-95. [Abstract] [Full-text]
5. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
   J Exp Med, 205(8): 1763-73. [Abstract] [Full-text]
6. HLA-DRB1*0401 and HLA-DRB1*0408 are strongly associated with the development of antibodies against interferon-beta therapy in multiple sclerosis.
   Am J Hum Genet, 83(2): 219-27. [Abstract] [Full-text]
7. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis.
   Proc Natl Acad Sci U S A, 105(32): 11358-63. [Abstract] [Full-text]
8. B cells and multiple sclerosis.
   Lancet Neurol, 7(9): 852-8. [Abstract] [Full-text]
9. Grey matter pathology in multiple sclerosis.
   Lancet Neurol, 7(9): 841-51. [Abstract] [Full-text]
10. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.
    Lancet Neurol, 7(9): 796-804. [Abstract] [Full-text]
11. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis.
    Clin Immunol, 128(3): 382-91. [Abstract] [Full-text]
12. Early identification of interferon-beta responders by ex vivo testing in patients with multiple sclerosis.
    Clin Immunol, 128(3): 306-13. [Abstract] [Full-text]
13. Effects of fluoxetine on disease activity in relapsing multiple sclerosis: a double-blind, placebo-controlled, exploratory study.
    J Neurol Neurosurg Psychiatry, 79(9): 1027-31. [Abstract] [Full-text]
14. Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations.
    J Neurol Neurosurg Psychiatry, 79(9): 1075-8. [Abstract] [Full-text]
15. Survival and cause of death in multiple sclerosis: a prospective population-based study.
    J Neurol Neurosurg Psychiatry, 79(9): 1016-21. [Abstract] [Full-text]
16. Bone-marrow transplantation fails to halt intrathecal lymphocyte activation in multiple sclerosis.
    J Neurol Neurosurg Psychiatry, 79(9): 1013-5. [Abstract] [Full-text]
17. Relapsing demyelinating disease affecting both the central and peripheral nervous systems.
    J Neurol Neurosurg Psychiatry, 79(9): 1032-9. [Abstract] [Full-text]
18. Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event.
    Proc Natl Acad Sci U S A, 105(33): 11839-44. [Abstract] [Full-text]
19. No effect of preterm birth on the risk of multiple sclerosis: a population based study.
    BMC Neurol, 8: 30. [Abstract] [Full-text]
20. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Neurology, 71(9): 632-8. [Abstract] [Full-text]
21. Disability as an outcome in MS clinical trials.
    Neurology, 71(9): 624-31. [Abstract] [Full-text]
22. Perivascular spaces--MRI marker of inflammatory activity in the brain?
    Brain, 131: 2332-40. [Abstract] [Full-text]
23. Neurogenesis in the chronic lesions of multiple sclerosis.
    Brain, 131: 2366-75. [Abstract] [Full-text]

© 2004-2010 Multiple Sclerosis Research Today. All Rights Reserved.